Industry News
Study Deciphers Components Of The Machinery That Duplicates DNA On Which Most Chemotherapeutic Agents Currently Act
Apr 29, 2013
The Genomic Instability Group led by researcher Oscar Fernandez-Capetillo at the Spanish National Cancer Research Centre (CNIO), has for the first time obtained a panoramic photo of the proteins that take part in human DNA division, a process known as replication... Read More
Three Different Diseases Controlled By One Gene
Apr 29, 2013
An international research consortium led by the Universitat Autonoma de Barcelona (UAB), the CIBERER and the University of Wurzburg (Germany) has discovered a gene that can cause three totally different diseases, depending on how it is altered. The researchers, using next-generation massive ultrasequencing techniques, have sequenced the over 20,000 genes of a Fanconi anaemia patient's genome... Read More
Prostate Cancer Gains Powerful Advantage With Abrupt Intervals Of Complex, Large Scale DNA Reshuffling
Apr 28, 2013
Cancer is typically thought to develop after genes gradually mutate over time, finally overwhelming the ability of a cell to control growth. But a new closer look at genomes in prostate cancer by an international team of researchers reveals that, in fact, genetic mutations occur in abrupt, periodic bursts, causing complex, large scale reshuffling of DNA driving the development of prostate cancer... Read More
Tamoxifen And Coffee Consumption May Help Prevent Return Of Breast Cancer
Apr 28, 2013
Drinking coffee could decrease the risk of breast cancer recurring in patients taking the widely used drug Tamoxifen, a study at Lund University in Sweden has found. Patients who took the pill, along with two or more cups of coffee daily, reported less than half the rate of cancer recurrence, compared with their non-coffee drinking, Tamoxifen-taking counterparts... Read More
Reviving A Foe Of Cancer
Apr 27, 2013
New research reveals how the tumor suppressor p53 is shut down in metastatic melanoma--and how it can be revived Cancer cells are a problem for the body because they multiply recklessly, refuse to die and blithely metastasize to set up shop in places where they don't belong. One protein that keeps healthy cells from behaving this way is a tumor suppressor named p53... Read More
Walgreens Presentation At Oncology Nursing Society Annual Congress Examines Therapy Benefits Of Home Nutrition Support For Patients With Cancer
Apr 27, 2013
Certain patients with cancer at risk for malnutrition may improve survival rates, response to treatment and quality of life by receiving nutrition therapy at home, according to information in a Walgreens Infusion Services'(NYSE: WAG) (Nasdaq: WAG) presentation today at the Oncology Nursing Society's 38th Annual Congress in Washington, D.C... Read More
Inherited Endocrine Tumor Syndrome Linked To Much-Studied Cell Pathway
Apr 27, 2013
A mutation in a protein called menin causes a hereditary cancer syndrome called MEN1 (multiple endocrine neoplasia type 1). Individuals with MEN1 are at a substantially increased risk of developing neuroendocrine tumors, including cancer of the pancreatic islet cells that secrete insulin... Read More
Effective Leukemia Drugs Too Expensive, Desperate Patients Left Untreated
Apr 26, 2013
Eleven of the 12 drugs approved for treating chronic myeloid leukemia (CML) and some other cancers cost over $100,000 per year, leaving many desperate patients either untreated or under-treated because they simply cannot afford care, nearly 120 CML experts from over 15 countries reported today in the journal Blood... Read More
Study Suggests Women On Medicaid More Likely To Receive Mastectomy To Treat Breast Cancer
Apr 26, 2013
JAMA Surgery Study Highlights In a study reported in the resident's forum, Linda Adepoju, M.D., of University of Toledo Medical Center, Ohio, and colleagues suggest that tumor size, cancer stage, and Medicaid insurance were predictors of undergoing a mastectomy to treat breast cancer... Read More
Study Examines Treatment Delays In Young Women With Breast Cancer By Race/Ethnicity
Apr 26, 2013
Young women with breast cancer who experience a longer treatment delay time (TDT) have significantly decreased survival time compared with those with a shorter TDT, especially African-American women, those with public or no insurance, and those with low socioeconomic status, according to a report published Online First by JAMA Surgery, a JAMA Network publication... Read More
Previous Page Next Page